Register of Legal Entities (JAR) · retrieved 3 November 2026
SODRA · as of 3 November 2026
Current number of insured employees (SODRA daily data) and the average gross salary (SODRA monthly data).
Centre of Registers, annual financial statements · retrieved 3 November 2026
Latest financial data available: fiscal year 2025.
Contact details as recorded in the registry; the company can correct them in its account.
A TOP season lists the companies that met the registry’s published criteria for that year. Being listed is not a paid status.
EBRS v7.0.0 · 13 of 13 signals computed · based on 12 years of this company’s data · computed on 3 November 2026
Dominant
Growing
12 in a row
EBRS signal system (v7.0.0): The score is calculated only from the data available. A signal without data is left out and its weight is redistributed among the active signals. Active signals for this company: 13 of 13. Each signal shows its score from 0 to 10.
EBRS (European Business Reputation Standard) scores a company from 0 to 10 using 13 signals grouped into 4 axes. Every signal is computed from public register data; a signal without data is left out, never estimated.
Confidence: The weighted average reliability of the data behind the signals, multiplied by their coverage. It is not a probability that the company meets its obligations.
How complete the public record of the company is.
Record in public procurement (Public Procurement Office data).
Absence from the register lists of companies that failed to file statements.
Management bodies recorded in the Register of Legal Entities.
Disclosure of shareholders in the JADIS participants register.
Scale of revenue and profit relative to the company size.
Direction and consistency of revenue over the filed years.
Margins and their stability over time.
Tax arrears recorded by the State Tax Inspectorate (VMI).
Years of operation and depth of the filed record.
Legal status in the Register of Legal Entities, including insolvency proceedings.
Ability to withstand revenue and market fluctuations.
Headcount, wages and social-insurance data (SODRA).
15 blocks of state register data are shown for this company; each figure has its own source date. In all, the registry assesses data from 14 state registers and other sources. The most recent of these blocks was retrieved on 3 November 2026.
Green - no warning found in this indicator · Amber - worth attention · Red - a risk signal · Grey - a neutral state or not enough data
Tax arrears: No tax arrears · Status as of: 3 November 2026
Legal status: Registered; no special legal status (such as liquidation or bankruptcy) is recorded (Teisinis statusas neįregistruotas) · Registered on: 29 April 1994
Financial statements: Not on the register lists of non-filers, late filers or missing audit reports
Manager (single-member management body): Present (management body registered on 23 December 2002; female) · Board: Present (formed on 8 November 2007) · Supervisory council: None recorded · Other management bodies: Present
Management bodies come from the Register of Legal Entities. The open register dataset does not publish personal names; the manager’s name comes from the company profile data and is checked separately. The registration date of a management body is not the appointment date of the current manager.
Declared participants: 1 · Lithuanian legal entities: 1
Counts of participants from the JADIS information system (open data, imported weekly). The dataset does not publish participants’ names or shareholdings. The owners’ nationality or residence has no effect on the EBRS score.
424 bids, 5,852 won (€41,197,457) · last contract 19 May 2023
Public Procurement Office (VPT) open data. Contracts the authority publishes without a supplier code cannot be attributed to a company, so some contracts may be missing.
491 contracts · total value €1223.6 million · latest 15 May 2023
26,006 published records · matched by the exact supplier code; coverage differs from the historical notices
111 cases · as defendant 16 · 115 hearings · latest hearing 27 May 2025
Average gross salary: €2,770 (September 2026) · Median gross salary: €2,298 (September 2026) · Middle 50% of salaries: €1,824 - €3,350 (September 2026)
Social-insurance contributions paid: €200,853 (September 2026) · Municipality (SODRA): Kauno r. sav.
104 vehicles · 55 Passenger cars (M1), 45 Light goods vehicles up to 3.5 t (N1), 3 Goods vehicles 3.5-12 t (N2), 1 Trailers up to 0.75 t (O1) · main fuel: Diesel · electric or hybrid: 20%
23 active, 2 expired: Amedi plus, VITA+ DAY, sinusyst, Odonte, ocusyst and 18 more
1 activity (1 active)
Source: State Patent Bureau (VPB) · retrieved 1 November 2026
Source: Regitra, register of motor vehicles · retrieved 3 October 2026
Valid and expired operating permits issued by Lithuanian state bodies. Total: 1. Retrieved 3 November 2026.
Veterinarinių vaistų, veikliųjų medžiagų tiekimas rinkai
Kauno apygardos priežiūros skyrius
Product categories and supervising offices are shown as published, in Lithuanian.
Official 2015-2026 VPT contract data. Records found for this company are dated from 2 January 2015 to 10 September 2026. Records are matched by the company code; contract amendments are not included. This is not a list of all the company’s contracts or tenders. These records are not added to the historical notices, because the same contract can appear in both sources. Conflicting records, unconfirmed dates and unclassified negative values are held back for review and are not shown here.
The current-year CVP IS data source was last changed on 20 October 2026. Contracts are linked to suppliers only up to 10 September 2026: the source has not yet published the parties of 142,562 contracts published later, so they are not shown here.
Vaistai (Klemastinas, 1 mg / ml)
Viešoji įstaiga Vilkpėdės ligoninė · 124245322
€719.04
10 September 2026
No. VPS-177 (6.27 Mr)/CPO397900-2904-3624 · CVP IS record ID 2008237102 · CPV 33670000-7 · Published value of the whole contract; VAT basis not confirmed.
Official source · CVPP_2026_APIVaistai (Drotaverino hidrochloridas 40 mg / 2 ml)
Viešoji įstaiga Vilkpėdės ligoninė · 124245322
€336.00
10 September 2026
No. VPS-176 (6.27 Mr)/CPO397898-2904-3624 · CVP IS record ID 2008237100 · CPV 33610000-9 · Published value of the whole contract; VAT basis not confirmed.
Official source · CVPP_2026_APIVaistai (Haloperidolis, 1,5 mg)
Viešoji įstaiga Vilkpėdės ligoninė · 124245322
€51.62
9 September 2026
No. VPS-174 (6.27 Mr)/CPO398446-2904-3624 · CVP IS record ID 2008237093 · CPV 33660000-4 · Published value of the whole contract; VAT basis not confirmed.
Official source · CVPP_2026_APISource: VPT open data (data.gov.lt) · Atn1ContractList · retrieved 1 November 2026
Contract objects and contracting authorities are shown as published, in Lithuanian. Public Procurement Office (VPT) open data. Contracts the authority publishes without a supplier code cannot be attributed to a company, so some contracts may be missing.
Full list in LithuanianSource: e.teismai.lt · Lithuanian courts · retrieved 31 October 2026
Lithuanian courts (e.teismai.lt, LITEKO). Court names are kept in Lithuanian.
Full list in LithuanianThe data reflect public official registers and are updated automatically. Their publication in this registry does not mean that Lietuvos TOP Įmonių Registras has verified or confirmed them independently. Names, addresses and other register text without an official English form are kept in Lithuanian. The reputation score (EBRS) is a calculated, derived value: see the methodology.
The Lithuanian profile is the primary edition. The itemised lists behind the summaries above (every contract, every court hearing, every vehicle), user reviews, media mentions and company-supplied descriptions and photos are published there only. Full profile in Lithuanian
Noticed an inaccuracy? The corrections page explains how to report it and what happens next.
Insured employees (SODRA): 345 (as of 3 November 2026) · Overdue to SODRA: None (as of 2 November 2026)
Contributions past their due date. SODRA’s published total also includes amounts under an agreed payment schedule; those are deducted here and shown separately.